PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29521111-9	2018	RESULTS: Good agreement was observed between C-peptide concentrations in plasma and equivalent DBS and VAMS samples ( R2 = .929 and .9231, DBS and VAMS, respectively), with mean differences of 75.7 and 8.4 pmol/L observed for DBS and VAMS.	dbs	139-142	insulin	Homo sapiens	45-54	
29521111-9	2018	RESULTS: Good agreement was observed between C-peptide concentrations in plasma and equivalent DBS and VAMS samples ( R2 = .929 and .9231, DBS and VAMS, respectively), with mean differences of 75.7 and 8.4 pmol/L observed for DBS and VAMS.	dbs	139-142	insulin	Homo sapiens	45-54	
29860430-10	2018	The correlation of the C-peptide slope over time (assessed by repeated home DBS) vs area under the curve during the two MMTTs was r = 0.73 (P < 0.001).	dbs	76-79	insulin	Homo sapiens	23-32	
29860430-11	2018	Mixed models showed that a 1-month increase in diabetes duration was associated with 17-pmol/L decline in fasting DBS C-peptide, whereas increases of 1 mmol/L in glucose, 1 year older age at diagnosis, and 100 pmol/L higher baseline plasma C-peptide were associated with 18, 17, and 61 pmol/L higher fasting DBS C-peptide levels, respectively.	dbs	114-117	insulin	Homo sapiens	118-127	
29521111-10	2018	Small decreases in C-peptide of 11.6% and 0.1% were observed after 48 hours storage for DBS and VAMS, respectively.	dbs	88-91	insulin	Homo sapiens	19-28	
29521111-11	2018	CONCLUSIONS: C-peptide collected using DBS and VAMS showed good agreement with reference plasma concentrations, suggesting both would be an effective microsampling method for collection and measurement of C-peptide.	dbs	39-42	insulin	Homo sapiens	13-22	
26565377-3	2016	AIM: The aim of this study is to determine the effect of haematocrit on insulin concentrations from DBS.	dbs	100-103	insulin	Homo sapiens	72-79	
26565377-5	2016	DBS were analysed for insulin using the method developed by Butter et al.	dbs	0-3	insulin	Homo sapiens	22-29	
26565377-11	2016	Plasma insulin concentrations from neonatal DBS were typically higher than paired plasma samples.	dbs	44-47	insulin	Homo sapiens	7-14	
26565377-12	2016	CONCLUSIONS: Haematocrit has a significant effect on insulin measurement by chemiluminescence when using DBS.	dbs	105-108	insulin	Homo sapiens	53-60	
26565377-14	2016	DBS insulin concentrations higher than plasma indicate that insulin may be present in red blood cells.	dbs	0-3	insulin	Homo sapiens	4-11	
26565377-14	2016	DBS insulin concentrations higher than plasma indicate that insulin may be present in red blood cells.	dbs	0-3	insulin	Homo sapiens	60-67	
26565377-15	2016	However, measuring plasma insulin concentrations with DBS in neonates is not ideal due to high variability.	dbs	54-57	insulin	Homo sapiens	26-33